The European Hematology Association (EHA)

Research

Publications

  1. Dreyling M, André M, Gökbuget N, Tilly H, Jerkeman M, Gribben J, Ferreri A, Morel P, Stilgenbauer S, Fox C, Ribera JM, Zweegman S, Aurer I, Bödör C, Burkhardt B, Buske C, Caballero MD, Campo E, Chapuy B, Davies A, de Leval L, Doorduijn J, Federico M, Gaulard P, Gay F, Ghia P, Grønbæk K, Goldschmidt H, Kersten MJ, Kiesewetter B, Landman-Parker J, Le Gouill S, Lenz G, Leppä S, Lopez-Guillermo A, Macintyre E, Mateos Mantega MV, Moreau P, Moreno C, Nadel B, Okosun J, Owen R, Pospisilova S, Pott C, Robak T, Spina M, Stamatopoulos K, Stary J, Tarte K, Tedeschi A, Thieblemont C, Trappe RU, Trümper LH, Salles G. The EHA Research Roadmap: Malignant Lymphoid Diseases. Hemasphere 2022; 6:6(e726). http://dx.doi.org/10.1097/HS9.0000000000000726.
  2. Horgan D, Walewski J, Aurer I, Visco C, Gine E, Fetica B, Jerkeman M, Kozaric M, Gomes da Silva M, Dreyling M. Tackling mantle cell lymphoma in Europe. Healthcare 2022; 10:1682. DOI: https://doi.org/10.3390/healthcare10091682
  3. Spanjaart AM, Ljungman P, de La Camara R, Tridello G, Ortiz-Maldonado V, Urbano-Ispizua A, Barba P, Kwon M, Caballero D, Sesques P, Bachy E, Di Blasi R, Thieblemont C, Calkoen F, Mutsaers P, Maertens J, Giannoni L, Nicholson E, Collin M, Vaz CP, Metafuni E, Martinez-Lopez J, Dignan FL, Ribera JM, Nagler A, Folber F, Sanderson R, Bloor A, Ciceri F, Knelange N, Ayuk F, Kroger N, Kersten MJ, Mielke S. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group. Leukemia. 2021 Dec;35(12):3585-3588. doi: 10.1038/s41375-021-01466-0. Epub 2021 Nov 8. PMID: 34750508; PMCID: PMC8573311.
  4. Dreyling M, Aurer I, Federico M, Jerkeman M, Kersten MJ, Linton K, Mey U, Tilly H, Buske C. EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic. Hemasphere. 2021 Jan 27;5(2):e529. doi: 10.1097/HS9.0000000000000529. PMID: 33880434; PMCID: PMC8051991.
  5. Milpied N, Dreyling M. Mantle Cell Lymphoma. 2022 Feb 7. In: Kröger N, Gribben J, Chabannon C, Yakoub-Agha I, Einsele H, editors. The EBMT/EHA CAR-T Cell Handbook [Internet]. Cham (CH): Springer; 2022. Chapter 13. PMID: 36122036.
  6. Glass B, Kersten MJ. Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-cell Lymphoma. 2022 Feb 7. In: Kröger N, Gribben J, Chabannon C, Yakoub-Agha I, Einsele H, editors. The EBMT/EHA CAR-T Cell Handbook [Internet]. Cham (CH): Springer; 2022. Chapter 12. PMID: 36122036.
  7. Ladetto M, Dreyling M. EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma. Hemasphere. 2021 Apr 21;5(5):e559. doi: 10.1097/HS9.0000000000000559. PMID: 33898930; PMCID: PMC8061678.
  8. Aurer I, Dreyling M, Federico M, Tilly H, Linton K, Kimby E, Chamuleau MED, Kersten MJ. Double Hit Lymphoma Diagnosis and Treatment in Europe-A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG). Hemasphere. 2020 Oct 20;4(6):e481. doi: 10.1097/HS9.0000000000000481. PMID: 33134867; PMCID: PMC7587423.